Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Novel Targets for Fast Antidepressant Responses: Possible Role of Endogenous Neuromodulators
Anderson Camargo, Ana Lúcia S. Rodrigues
Chronic Stress (2019) Vol. 3
Open Access | Times Cited: 26

Showing 1-25 of 26 citing articles:

Role of Inflammatory Mechanisms in Major Depressive Disorder: From Etiology to Potential Pharmacological Targets
Bruna R. Kouba, Laura A. Borba, Pedro Borges de Souza, et al.
Cells (2024) Vol. 13, Iss. 5, pp. 423-423
Open Access | Times Cited: 71
Depression: Biological markers and treatment
Gordana Nedić Erjavec, Marina Šagud, Matea Nikolac Perković, et al.
Progress in Neuro-Psychopharmacology and Biological Psychiatry (2020) Vol. 105, pp. 110139-110139
Closed Access | Times Cited: 88
Agmatine as a novel intervention for Alzheimer's disease: Pathological insights and cognitive benefits
Raj Katariya, Shivkumar S. Sammeta, Mayur B. Kale, et al.
Ageing Research Reviews (2024) Vol. 96, pp. 102269-102269
Closed Access | Times Cited: 7
Agmatine modulation of gut-brain axis alleviates dysbiosis-induced depression-like behavior in rats
Sandip Rahangdale, Pankaj Deshmukh, Shivkumar S. Sammeta, et al.
European Journal of Pharmacology (2024) Vol. 981, pp. 176884-176884
Closed Access | Times Cited: 5
Neuroprotection by agmatine: Possible involvement of the gut microbiome?
Priyanka Saha, Subhrajita Panda, Aayusha Holkar, et al.
Ageing Research Reviews (2023) Vol. 91, pp. 102056-102056
Closed Access | Times Cited: 13
Exploring the Molecular Targets for the Antidepressant and Antisuicidal Effects of Ketamine Enantiomers by Using Network Pharmacology and Molecular Docking
Glorister A. Altê, Ana Lúcia S. Rodrigues
Pharmaceuticals (2023) Vol. 16, Iss. 7, pp. 1013-1013
Open Access | Times Cited: 12
Testosterone synthesis was inhibited in the testis metabolomics of a depression mouse model
Guanghui Chen, Wenbin Zhang, Dongyan Li, et al.
Journal of Affective Disorders (2024) Vol. 350, pp. 627-635
Closed Access | Times Cited: 4
A single administration of ascorbic acid rapidly reverses depressive-like behavior and hippocampal synaptic dysfunction induced by corticosterone in mice
Daiane B. Fraga, Anderson Camargo, Gislaine Olescowicz, et al.
Chemico-Biological Interactions (2021) Vol. 342, pp. 109476-109476
Closed Access | Times Cited: 27
Sex-based differences in the prevention of stress-induced anxiety by Resolvin D5 and its precursor docosahexaenoic acid: A comparative study
J.J. Fedriani de Matos, Alvaro Henrique Bernardo de Lima Silva, Matheus Vinícius Ferreira, et al.
Brain Research (2025), pp. 149612-149612
Closed Access
Antidepressant-like effect of guanosine involves activation of AMPA receptor and BDNF/TrkB signaling
Priscila B. Rosa, Luis E.B. Bettio, Vivian B. Neis, et al.
Purinergic Signalling (2021) Vol. 17, Iss. 2, pp. 285-301
Open Access | Times Cited: 22
Drug Repurposing for the Management of Depression: Where Do We Stand Currently?
Hosna Mohammad Sadeghi, Ida Adeli, Taraneh Mousavi, et al.
Life (2021) Vol. 11, Iss. 8, pp. 774-774
Open Access | Times Cited: 21
Ketamine, but not guanosine, as a prophylactic agent against corticosterone-induced depressive-like behavior: Possible role of long-lasting pro-synaptogenic signaling pathway
Anderson Camargo, Ana Paula Dalmagro, Márcia María de Souza, et al.
Experimental Neurology (2020) Vol. 334, pp. 113459-113459
Open Access | Times Cited: 23
Agmatine as a novel candidate for rapid-onset antidepressant response
Ana Paula Valverde, Anderson Camargo, Ana Lúcia S. Rodrigues
World Journal of Psychiatry (2021) Vol. 11, Iss. 11, pp. 981-996
Open Access | Times Cited: 20
Subthreshold doses of guanosine plus ketamine elicit antidepressant-like effect in a mouse model of depression induced by corticosterone: Role of GR/NF-κB/IDO-1 signaling
Anderson Camargo, Ana Paula Dalmagro, Júlia M. Rosa, et al.
Neurochemistry International (2020) Vol. 139, pp. 104797-104797
Closed Access | Times Cited: 19
Low doses of ketamine and guanosine abrogate corticosterone-induced anxiety-related behavior, but not disturbances in the hippocampal NLRP3 inflammasome pathway
Anderson Camargo, Ana Paula Dalmagro, Daiane B. Fraga, et al.
Psychopharmacology (2021) Vol. 238, Iss. 9, pp. 2555-2568
Closed Access | Times Cited: 17
A low-dose combination of ketamine and guanosine counteracts corticosterone-induced depressive-like behavior and hippocampal synaptic impairments via mTORC1 signaling
Anderson Camargo, Ana Paula Dalmagro, Ingrid A.V. Wolin, et al.
Progress in Neuro-Psychopharmacology and Biological Psychiatry (2021) Vol. 111, pp. 110371-110371
Closed Access | Times Cited: 16
Guanosine potentiates the antidepressant-like effect of subthreshold doses of ketamine: Possible role of pro-synaptogenic signaling pathway
Anderson Camargo, Ana Paula Dalmagro, Ana Lúcia Bertarello Zeni, et al.
Journal of Affective Disorders (2020) Vol. 271, pp. 100-108
Closed Access | Times Cited: 15
New Insights Into the Pivotal Role of CREB-Regulated Transcription Coactivator 1 in Depression and Comorbid Obesity
Clara Rossetti, Antoine Cherix, Laetitia Guiraud, et al.
Frontiers in Molecular Neuroscience (2022) Vol. 15
Open Access | Times Cited: 10
From antioxidant to neuromodulator: The role of ascorbate in the management of major depression disorder
Nuno R. Ferreira, Carla Vitorino, Ana Fortuna
Biochemical Pharmacology (2022) Vol. 206, pp. 115300-115300
Closed Access | Times Cited: 8
Agmatine diminishes behavioral and endocrine alterations in a rat model of post-traumatic stress disorder
Mayur B. Kale, Sandip Rahangdale, Trupti A. Banarase, et al.
Neuroscience Letters (2024), pp. 138074-138074
Closed Access | Times Cited: 1
Guanosine boosts the fast, but not sustained, antidepressant-like and pro-synaptogenic effects of ketamine by stimulating mTORC1-driven signaling pathway
Anderson Camargo, Ana Paula Dalmagro, Eslen Delanogare, et al.
European Neuropsychopharmacology (2022) Vol. 57, pp. 15-29
Closed Access | Times Cited: 6
The memory modulatory effect of agmatine in passive avoidance task coincides with alterations of hippocampal CaMKII-α and ERK signaling in mice
Majid Reza Farokhi, Erfan Taherifard, Roksana SoukhakLari, et al.
European Journal of Pharmacology (2022) Vol. 923, pp. 174928-174928
Closed Access | Times Cited: 6
Exploring the Molecular Targets for the Antidepressant and Antisuicidal Effects of Ketamine Enantiomers by using Network Pharmacology and Molecular Docking
Glorister A. Altê, Ana Lúcia S. Rodrigues
(2023)
Open Access | Times Cited: 3
Proposed Neuroimmune Roles of Dimethyl Fumarate, Bupropion, S-Adenosylmethionine, and Vitamin D3 in Affording a Chronically Ill Patient Sustained Relief from Inflammation and Major Depression
Navzer D. Sachinvala, Naozumi Teramoto, Angeline Stergiou
Brain Sciences (2020) Vol. 10, Iss. 9, pp. 600-600
Open Access | Times Cited: 8
Guanosine as a promising target for fast-acting antidepressant responses
Anderson Camargo, Ana Lúcia S. Rodrigues
Pharmacology Biochemistry and Behavior (2022) Vol. 218, pp. 173422-173422
Closed Access | Times Cited: 4
Page 1 - Next Page

Scroll to top